SCHEMBL6434222

SCHEMBL6434222

CC1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CCCN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 2/20 0.64
FYN P06241 2/20 0.64
ADORA3 P0DMS8 2/20 0.64
MAPK3 P27361 2/20 0.64
HTR2C P28335 2/20 0.64
DRD3 P35462 2/20 0.64
HTR2B P41595 2/20 0.64
MAPK14 Q16539 2/20 0.64
EGFR P00533 1/20 0.64
PGR P06401 1/20 0.64
ADRB2 P07550 1/20 0.64
CHRM2 P08172 1/20 0.64
ADRA2A P08913 1/20 0.64
AR P10275 1/20 0.64
ADRA2C P18825 1/20 0.64
DRD1 P21728 1/20 0.64
PTGS1 P23219 1/20 0.64
HRH2 P25021 1/20 0.64
PDE4A P27815 1/20 0.64
HTR2A P28223 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4928160 1.00 LCK (0.64) LCKFYNADORA3MAPK3HTR2C
SCHEMBL9206259 0.97 EGFR (0.61) LCKFYNADORA3MAPK3HTR2C
SCHEMBL9198078 0.86 HTR2A (0.47) LCKFYNADORA3MAPK3HTR2C
SCHEMBL10695802 0.85 EGFR (0.46) LCKFYNADORA3MAPK3HTR2C
SCHEMBL31066921 0.83 CASP1 (0.48) LCKFYNADORA3MAPK3HTR2C
SCHEMBL4877668 0.82 ALDH1A1 (0.74) LCKFYNADORA3MAPK3HTR2C
Hydrochloric Acid SCHEMBL10720129 0.81 ALDH1A1 (0.73) LCKFYNADORA3MAPK3HTR2C
Hydrochloric Acid SCHEMBL9725003 0.80 CASP1 (0.54) LCKFYNADORA3MAPK3HTR2C
SCHEMBL9200492 0.80 EGFR (0.41) LCKFYNADORA3MAPK3HTR2C
SCHEMBL9069451 0.79 CYP19A1 (0.52) LCKFYNADORA3MAPK3HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016243-A2 COMPOSITIONS OF A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS PHARMACIA CORPORATION (US) 2005-02-24 WO claimed